Is the business good?
How good a business is AORT?
Artivion, Inc. earns 4.8% on the capital it employs against a 9.0% cost of capital, so growth costs more than it returns.
4.8%
Return on invested capital · cost of capital 9.0% · 4.2 points below what the capital costs: growth destroys value
- Operating margin
- 8.2%
Operating margin · Medical Devices median 11% · 12 months to Q1 2026
- Cash conversion
- 1.25×
Cash conversion · every dollar of reported profit arrived as cash, and more
- Share count, year on year
- +18%
Share count, year on year · shareholders own a smaller slice than a year ago
| Year | Operating margin |
|---|---|
| FY2020 | 0.96% |
| FY2021 | 2.7% |
| FY2022 | 2.0% |
| FY2023 | 1.6% |
| FY2024 | 10% |
| FY2025 | 7.6% |
Details›
- Gross margin12 months to Q1 2026
- 65%
- Operating margin12 months to Q1 2026
- 8.2%
- Net margin12 months to Q1 2026
- 2.5%
- Free cash flow margin
- 3.2%
- R&D as % of revenue
- 7.2%
- Revenue, trailing twelve months
- $459M
- Free cash flow, trailing twelve months
- $15M
- Net income, trailing twelve months
- $12M
- Return on invested capitaloperating profit after tax ÷ debt + equity − cash
- 4.8%
Margins, capital and share counts from the statements as filed with the SEC; cash conversion from the cash flow statement.